Drug
Finerenone
Finerenone: highest development phase Approved, developed by Bayer. 2 trial records tracked on RxWires.
- Highest phase
- Approved
- Developer
- Bayer
Trials
| Drug | Phase | Indication |
|---|---|---|
| KERENDIA | Approved | |
| Finerenone (Kerendia, BAY94-8862) NCT07192952 | Phase 3 | Left Ventricular Systolic Dysfunction |
Latest
No recent events.
Follow Finerenone on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.